Strength
5 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173068101
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Last Updated
1/22/2025
Active Ingredients
ZANAMIVIRApproval Type
New Drug (NDA)
FDA Application
NDA021036On Market Since
9/22/1999
Pharmacological Classes
Neuraminidase Inhibitor
Neuraminidase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification